MVision AI
News and Articles

Keep up to date with our latest articles

Hot Topics 🔥

Press Room

8.1.2024

Merging (Artificial) Intelligence and Ethics in Radiation Oncology – Why and How?

”Our future is a race between the growing power of technology and the wisdom with which we use it.” This statement of Stephen Hawking, the well known physicist, mathematician and visionary, summarizes very well the present challenges. A new technology, irrespective of its degree of complexity, makes an impact in…

Articles

8.1.2024

LEARN. PREVENT. SCREEN. CERVICAL CANCER CAN BECOME HISTORY.

January is Cervical Cancer Awareness Month, and these three core principles are emphasized during the 2024 campaign. Nowadays, cervical cancer is responsible for more than 300,000 deaths each year globally. Fortunately, we have the tools to prevent it, diagnose it early, and treat it efficiently in most cases. This is…

Articles

7.12.2023

AI-based auto-contouring – What to expect?

Time is money but it’s even more than that - time is life. Radiotherapy is one of the medical fields in which technological advances find a proper receptor. We find new ways to use outstanding computer capabilities to increase the quality of services and focus on the next steps to…

Articles

27.11.2023

Lymph nodes irradiation for breast cancer – outlines from the Early Breast Cancer Trialists’ Collaborative Group meta-analysis

An important article for clinical practice  was recently published in “The Lancet”. The conclusions are based on the meta-analysis of 16 trials and represents a trustable proof on impact of radiotherapy of the lymph node regions in breast cancer radiotherapy. It is important to mention that individual patient data  from…

Articles

24.11.2023

MVision AI and Institut de Cancérologie de Lorraine (ICL, Nancy) announce the first installation of unique Guide and Verify solutions for cancer treatment in France

HELSINKI, Finland - November 24, 2023 Institut de Cancérologie de Lorraine (ICL) in Nancy (France) has been a MVision AI customer since the installation of Contour+ in January 2023. This year, the values of using Guideline-Based AI Segmentation in daily practice have been prominently featured in several French media outlets…

Press Releases

13.11.2023

The future of AI in Radiotherapy, and how does MVision AI plan to further enhance its offerings in this field

The interview of Jarkko Niemelä, CEO, and Co-founder of MVision AI, for IntelligentHealth.tech magazine. October 2023. What specific challenges does Contour+ address in the field of radiotherapy, and how does its AI-powered automation contribute to overcoming these challenges? The largest challenge in cancer radiotherapy is the shortage of experts, including…

Articles

10.11.2023

Man vs. Machine (Learning): Comparing Speed and Cost-Effectiveness of Manual vs. Deep Learning Segmentation-Aided Volume Delineation for Head and Neck Lymph Node Targets

This preliminary study shows that using an AI-based segmentation-aided approach to Head and Neck Lymph Node stations can be feasibly implemented within a standard Radiation Oncology workflow!MVision AI's guideline-based Contour+ offers the potential for significant time and cost savings in your Radiation Therapy department.

Articles

27.10.2023

MVision AI is proud to announce the installation of its Contour+ at Nemocnica Bory Hospital in Slovakia

HELSINKI, Finland - October 27, 2023 MVision AI has been chosen as the preferred provider of an auto-contouring solution (Contour+) for the radiation therapy department, under the leadership of MUDr. Margita Pobijáková, PhD. Additionally, the company is an integral part of the Oncology program, alongside Elekta Linac and the first…

Press Releases

23.10.2023

MVision AI Contour+ (Guideline-Based AI Segmentation): highlights from an independent validation study using a comprehensive and curated data set

Overall, 87% of the radiation oncologists who participated in the study gave the MVision AI Contour+ a score of 4 or 5 (minor or no editing required). How to properly test an AI-based auto-contouring solution? Artificial-intelligence applications are becoming increasingly popular in medicine, including Radiotherapy. Before AI-based tools can be…

Articles

19.10.2023

Breast cancer radiotherapy – Exciting news about concomitant boost for hypofractionated treatment schedules

One of the important studies presented at the recent ASTRO 2023 meeting provided strong evidence for  the safety and efficacy of concomitant boost during hypofractionated radiotherapy for breast cancer. Currently, about 60% of women with breast cancer receive conservative surgery, followed by radiotherapy (1). Previous studies showed that for conservative…

Articles

10.10.2023

The clinician of the future – empowered by AI

Elsevier Health recently published a “Clinician of the future” report, based on the results of an online survey which gathered the perspectives of more than 2600 clinicians from 116 countries. They expressed their opinions on the future of healthcare, the opportunities and challenges they are facing in their roles. Perspectives…

Articles

29.9.2023

MVision AI is proud to announce the launch of the world’s first comprehensive Guideline-Based Segmentation (GBS™) solution for responsible radiation therapy contouring

HELSINKI, Finland - September 29, 2023 The launch of MVision AI’s GBS™ solution is timed to coincide with the release of two new products - Guide and Verify. Guide empowers clinical teams to competently review AI-generated structures, thereby helping them to refine their contouring skills. Our solution offers a library…

Press Releases

Testimonials

Hear what people say about us.

Customer Portfolio